Stay updated on Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page.

Latest updates to the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed. No study data, eligibility criteria, or navigation elements were altered.SummaryDifference0.0%

- Check12 days agoChange DetectedFooter revision updated to v3.4.3; the page content remains unchanged.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new site revision label 'Revision: v3.4.2' is added, and previous notices about government funding lapses and NIH operating status are removed.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a site-wide funding notice about government appropriations and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check55 days agoChange DetectedAdded a glossary toggle, introduced a new 'Last Update Submitted that Met QC Criteria' field, and updated the revision label to v3.4.0, with minor wording changes to QC/FEAR Act data.SummaryDifference0.2%

- Check69 days agoChange DetectedThe page adds Revision: v3.3.4 and removes Revision: v3.3.3 as part of a metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page.